NEUROECTODERMAL TUMORS, PRIMITIVE
Clinical trials for NEUROECTODERMAL TUMORS, PRIMITIVE explained in plain language.
Never miss a new study
Get alerted when new NEUROECTODERMAL TUMORS, PRIMITIVE trials appear
Sign up with your email to follow new studies for NEUROECTODERMAL TUMORS, PRIMITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Killer virus turned against childhood brain cancer
Disease control Recruiting nowThis early-stage trial tests whether a specially engineered herpes virus (G207) is safe to inject directly into the brain tumors of children whose cancer has returned. Up to 24 children aged 3 to 21 will receive the virus, and some will also get a small dose of radiation to help …
Matched conditions: NEUROECTODERMAL TUMORS, PRIMITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New pill shows promise in early brain tumor trial
Disease control Recruiting nowThis early-stage study tests an oral drug called ONC206 in adults with brain tumors that have come back. The main goal is to find the safest dose and check for side effects. About 102 participants will take the drug once or several times a week.
Matched conditions: NEUROECTODERMAL TUMORS, PRIMITIVE
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC